Predicting endoscopic remission in Crohn's disease by the modified multiplier SES-CD (MM-SES-CD).
Neeraj NarulaEmily Chu Lee WongJean-Frederic ColombelWilliam J SandbornJohn Kenneth MarshallMarco DapernoWalter ReinischParambir S DulaiPublished in: Gut (2021)
We developed and internally validated the MM-SES-CD as an endoscopic severity assessment tool to predict one-year ER in patients with CD on active therapy.